Why is Modern Cannabis More Potent than It Used to Be?

Average THC concentrations have risen substantially in many cannabis markets over recent decades. Selective breeding, cultivation practices and a larger market for concentrates help explain the change. But a historical average is not a description of every product from that era, and high THC content is not the same as better quality or greater medical benefit.

What the Historical Data Actually Show

A systematic review published online in 2020 found rising THC concentrations in herbal cannabis and resin across studies from seven countries. For herbal cannabis, the pooled increase was about 0.29 percentage points per year over the included 1970–2017 data. That is an estimated trend across samples, not a claim that every strain gained the same amount each year.

The same review found no clear change in average CBD concentrations in the datasets examined. The availability of deliberately bred CBD-rich products should not be confused with evidence that both THC and CBD increased across the entire market.

In US monitoring data, an analysis covering 1995–2014 reported average THC rising from approximately 4% to approximately 12%. These were confiscated samples submitted through DEA laboratories, rather than a random survey of everything Americans consumed.

A later study covering 2013–2022 also examined regional differences in confiscated material. Such surveillance is useful, but seizure patterns, sample composition and testing methods limit comparisons with a particular dispensary shelf. Claims that virtually all older cannabis was weak, or that every modern flower exceeds 20% THC, go beyond what these data establish.

Why Potency Increased

Selection and Breeding

Growers can select plants for cannabinoid production and propagate desirable selections. Repeated selection changes the plant material available over generations. This process predates modern legal retail markets; legalization is not the starting point of cannabis breeding.

A 2025 study comparing two modern cultivars with two traditional landraces found larger glandular trichomes, more secretory cells and greater metabolic activity in the modern examples. It offers a biological explanation for improved production in those plants. Four examples cannot establish that every modern cultivar outperforms every landrace.

Cultivation and Product Selection

Plant genetics operate within growing conditions. Growers manage light, nutrition, health and harvest timing, while selecting flowers and handling them after harvest. These choices affect composition and consistency. Increasing one input does not necessarily increase potency, and poor storage can undermine a high-quality harvest.

Demand for high-THC products also gives producers a reason to select and market them. That commercial incentive helps explain product availability, but it does not show that higher percentages meet every consumer’s needs.

Concentrates Change the Comparison

Concentrating resin or extracting cannabinoids removes much of the other plant material. The resulting product can contain far more THC per gram than flower. Comparing modern concentrate percentages with historical flower averages mixes two product categories.

For illustration, 1 gram of a product containing 20% THC corresponds to 200 milligrams of THC, while 1 gram at 80% corresponds to 800 milligrams. These are amounts in the material, not amounts absorbed by the body or suggested doses. Labels may report total potential THC, and processing and route of use affect exposure.

What Higher THC Means for Health

A 2022 systematic review associated higher-potency use with greater risks of psychosis and cannabis use disorder; findings for depression and anxiety were less consistent. Much of the evidence was observational, so frequency, prior health and other differences between users need consideration. Those limitations do not justify dismissing the associations.

THC exposure itself matters. Addiction is not simply an unrelated personal trait that a substance cannot influence. Product strength, frequency and patterns of use interact with individual vulnerabilities. Tolerance may reduce some noticeable effects without establishing that someone is unimpaired or protected from longer-term problems.

A review of dose adjustment with stronger cannabis found some evidence that users can compensate, but less evidence that regular users reliably do so in practice. Using a stronger product does not automatically mean a person will consume proportionately less THC.

Choosing Beyond the Highest Percentage

Compare the product format, measured cannabinoid content and amount used. A familiar strain name cannot substitute for the current batch label. CBD and terpenes should not be treated as antidotes that reliably cancel unwanted THC effects.

For a medical purpose, assess the evidence for the specific condition and formulation with a clinician. High-THC flower is not automatically the appropriate treatment for pain, nausea or migraine. Avoid driving while impaired and be especially cautious when changing products or returning after a break in use.

The rise in potency is real across many studied markets. Understanding what was measured, how the product was made and how much THC it delivers is more useful than treating strength as a universal measure of value.